{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Norman+Lamb&tablingMemberConstituency=North+Norfolk&answeringDeptSortName=Health+and+Social+Care&questionText=To+ask+the+Secretary+of+State+for+Health+and+Social+Care%2C+what+recent+assessment+he+has+made+of+the+adequacy+of+the+availability+of+anti-epilepsy+medications+in+the+event+that+the+UK+leaves+the+EU+without+a+deal.", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Norman+Lamb&tablingMemberConstituency=North+Norfolk&answeringDeptSortName=Health+and+Social+Care&questionText=To+ask+the+Secretary+of+State+for+Health+and+Social+Care%2C+what+recent+assessment+he+has+made+of+the+adequacy+of+the+availability+of+anti-epilepsy+medications+in+the+event+that+the+UK+leaves+the+EU+without+a+deal.", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Norman+Lamb&tablingMemberConstituency=North+Norfolk&answeringDeptSortName=Health+and+Social+Care&_metadata=all&questionText=To+ask+the+Secretary+of+State+for+Health+and+Social+Care%2C+what+recent+assessment+he+has+made+of+the+adequacy+of+the+availability+of+anti-epilepsy+medications+in+the+event+that+the+UK+leaves+the+EU+without+a+deal.", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Norman+Lamb&_page=0&tablingMemberConstituency=North+Norfolk&answeringDeptSortName=Health+and+Social+Care&questionText=To+ask+the+Secretary+of+State+for+Health+and+Social+Care%2C+what+recent+assessment+he+has+made+of+the+adequacy+of+the+availability+of+anti-epilepsy+medications+in+the+event+that+the+UK+leaves+the+EU+without+a+deal.", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Norman+Lamb&tablingMemberConstituency=North+Norfolk&answeringDeptSortName=Health+and+Social+Care&questionText=To+ask+the+Secretary+of+State+for+Health+and+Social+Care%2C+what+recent+assessment+he+has+made+of+the+adequacy+of+the+availability+of+anti-epilepsy+medications+in+the+event+that+the+UK+leaves+the+EU+without+a+deal.", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Norman+Lamb&tablingMemberConstituency=North+Norfolk&answeringDeptSortName=Health+and+Social+Care&questionText=To+ask+the+Secretary+of+State+for+Health+and+Social+Care%2C+what+recent+assessment+he+has+made+of+the+adequacy+of+the+availability+of+anti-epilepsy+medications+in+the+event+that+the+UK+leaves+the+EU+without+a+deal.", "items" : [{"_about" : "http://data.parliament.uk/resources/1149339", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1149339/answer", "answerText" : {"_value" : "

The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including those used for the treatment of epilepsy, once we have left the EU.<\/p>

The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:<\/p>

https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans<\/a><\/p>

We have been working closely with suppliers to monitor over 300 different epilepsy medicines provided by almost 50 companies and we are pleased to see many are holding stockpiles far beyond the six weeks\u2019 additional buffer we requested. We also know that the vast majority of those suppliers with lower levels of stockpiles are taking action to re-route their supply chains away from the short straits crossings where applicable.<\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "dateOfAnswer" : {"_value" : "2019-10-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-21T13:04:06.75Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Epilepsy: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of the availability of anti-epilepsy medications in the event that the UK leaves the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"} } , "tablingMemberConstituency" : {"_value" : "North Norfolk"} , "tablingMemberPrinted" : [{"_value" : "Norman Lamb"} ], "uin" : "479"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }